FHTX 8-K 2026-01-12

Foghorn Therapeutics Inc. (FHTX) 8-K dated 2026-01-12 — accession 0001193125-26-009885. This URL is the filing, not the FHTX hub.

Foghorn Therapeutics Inc. (FHTX) is a biotechnology company listed on NASDAQ.

Foghorn Therapeutics Inc. filed a 8-K on 2026-01-12. Accession 0001193125-26-009885.

Cached items: 2.02, 7.01, 8.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported FHTX revenue for 2026-06-30 was $19.3M. Net income was -$27.1M. FHTX currently screens at market cap $237.8M.

Not investment advice. The FHTX SEC hub lists recent forms. The stock page is the research view.